Visit our website at 2024 Registration and register to secure your spot at the 20th ISDE World Congress for Esophageal Diseases.

We are excited to share with you the detailed Scientific Program!

ISDE invites applications for the Co-Editor-in-Chief position for Diseases of the Esophagus Journal. With a legacy spanning back to 1986, DOTE stands as a premier publication in esophageal diseases, boasting a global readership. We are seeking a distinguished gastroenterologist or medical professional with expertise in esophageal diseases to shape the journal's trajectory alongside Magnus Nilsson from Karolinska Institute. The ideal candidate will champion diversity, possess editorial acumen, and drive innovation in scholarly publishing. View the Position Description for more information and submit an application online.

DOTE - Volume 37, Issue 3, March 2024

The latest issue of Diseases of the Esophagus Journal is now available online.

Expert Reviews

Systematic Reviews and Meta-analysis

Benign Esophageal Disease

Subscribe to email alerts

Are the Chicago 3.0 manometric diagnostics consistent with Chicago 4.0? 

What is the concordance between the results obtained using the Chicago classification v3.0 compared to 4.0 protocol to interpret high resolution manometry (HRM)?

1)     Study of 132 patients (65% women). Most frequent indication was dysphagia (46.1%)

2)     Most frequent CC v4.0 diagnoses were normal (68.9%), achalasia (15.5%) and IEM (5.3%)

3)     Total agreement between v3.0 and v4.0 was 87.9% for diagnoses. Diagnostic reclassification occurred in 12.1% from IEM in v3.0 to normal in v4.0.

4)     High level of agreement between the IRP measured in supine compared to seated position and with solid swallows.

5)     In majority of manometric diagnoses, there is no reclassification of patients with provocation tests.

Clinical value of random esophageal biopsies in patients with dysphagia and normal endoscopy who are treated with a proton pump inhibitor

Rome IV recommends esophageal biopsies in patients with dysphagia and normal endoscopy to exclude mucosal disease, but is it helpful? In this study of 361 patients, random esophageal biopsies in patients on PPI treatment with dysphagia and normal endoscopy were obtained.

1)     No difference in biopsy results between those with and without heartburn in patients with dysphagia and normal endoscopy.

2)     Most common finding was microscopic gastroesophageal reflux disease (39%)

3)     Number of abnormal biopsies was significantly higher than normal biopsies (68% and 32%, respectively, P <0.01).

Visit the ISDE Literature Updates Online for more.

20th ISDE World Congress in Edinburgh, Scotland 2024 click HERE for more information.

DDW 2024 will take place May 18-21, 2024, in Washington, D.C. and online.

UEG Week October 12 -16, 2024, in Vienna, Austria

Japan Digestive Disease Week 2024 October 31 - November 03, 2024, in Kobe, Japan

Additional events of interest to the ISDE members and community can be found on the ISDE Events Calendar.

All communications will generally come from membership@isde.net, please be aware of spam/malicious emails using ISDE information.